Pulmonary fibrosis represents a progressive and debilitating group of disorders characterized by irreversible lung scarring. This session will focus on mechanisms underlying fibrosis and lung remodeling. Researchers will discuss molecular pathways, biomarkers, and emerging therapeutic strategies. Recent advances in antifibrotic treatments will be highlighted.
Presentations will examine disease progression, imaging techniques, and novel diagnostic approaches. Participants will gain insights into clinical management strategies and personalized treatment options. Translational research findings and clinical trial outcomes will also be discussed. Emerging regenerative approaches for fibrotic lung disease will be presented.
The session will address challenges associated with early diagnosis, treatment response, and disease monitoring. Experts will discuss future opportunities in fibrosis research and precision medicine. Collaborative efforts aimed at improving patient outcomes will be encouraged. This session aims to advance innovation in pulmonary fibrosis management.